When dichotomized into SOH (53 patients) and AH (101 patients) subgroups (Figure 2A), patients in the SOH subgroup had significantly shorter overall survival (p = 0.029; Figure 2B), suggesting that activation of YAP1/TAZ is associated with poor prognosis in GBM. Here, YAP1 is linked to glioblastoma.